XML 23 R6.htm IDEA: XBRL DOCUMENT v3.23.2
Consolidated Statement of Changes in Equity - CAD ($)
$ in Millions
Total
Attributable to equity holders of the Company
Common shares
Contributed surplus
Accumulated other comprehensive income
Retained earnings
Non-controlling interests
Number of shares (in shares) at Mar. 31, 2021     293,355,463        
Balances, beginning of year at Mar. 31, 2021 $ 3,212.8 $ 3,140.5 $ 1,516.2 $ 22.5 $ 58.1 $ 1,543.7 $ 72.3
Net income 150.0 141.7       141.7 8.3
Other comprehensive (loss) income (13.2) (11.9)     (104.1) 92.2 (1.3)
Total comprehensive income 136.8 129.8     (104.1) 233.9 7.0
Issuance of common shares under an equity offering/ subscription receipts (in shares)     22,400,000        
Issuance of common shares upon conversion of subscription receipts 689.7 689.7 $ 677.2 12.5      
Exercise of stock options (in shares)     1,268,660        
Exercise of stock options 27.1 27.1 $ 31.3 (4.2)      
Share-based payments expense 7.8 7.8   7.8      
Transfer of realized cash flow hedge losses related to business combinations 14.8 14.8     14.8    
Transactions with non-controlling interests (2.4)           (2.4)
Number of shares (in shares) at Mar. 31, 2022     317,024,123        
Balances, end of year at Mar. 31, 2022 4,086.6 4,009.7 $ 2,224.7 38.6 (31.2) 1,777.6 76.9
Net income 231.9 222.7       222.7 9.2
Other comprehensive (loss) income 257.0 252.9     198.4 54.5 4.1
Total comprehensive income 488.9 475.6     198.4 277.2 13.3
Exercise of stock options (in shares)     882,167        
Exercise of stock options 16.3 16.3 $ 18.9 (2.6)      
Share-based payments expense 6.1 6.1   6.1      
Transactions with non-controlling interests (9.0)           (9.0)
Number of shares (in shares) at Mar. 31, 2023     317,906,290        
Balances, end of year at Mar. 31, 2023 $ 4,588.9 $ 4,507.7 $ 2,243.6 $ 42.1 $ 167.2 $ 2,054.8 $ 81.2